Candelanza, Mary Joy M.

HRN: 19-41-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2025
CEFTRIAXONE 1G (VIAL)
09/17/2025
09/24/2025
IVT
2g
OD
CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric Then Culture-directed    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines